Literature DB >> 2182940

Malaria prophylaxis in travellers to tropical Africa.

T Weinke1, G Weber, U Schultes, W Hopfenmüller, K Janitschke.   

Abstract

This study investigated travellers to tropical Africa with regard to prophylactic treatment of malaria. A total of 5703 travellers completed a questionnaire on their flights back to the Federal Republic of Germany; 4116 passengers (73.7%) had visited East Africa, while 808 (14.5%) had been to West Africa. The results indicate that 90.2% took a regular chemoprophylaxis against malaria. Nevertheless, 8.1% of the travellers used no antimalarials and in 9.3% chemoprophylaxis was inadequate due to inappropriate advice; for example, 7.5% still took pyrimethamine-sulfadoxine as prophylactic. Mefloquine was correctly taken by 38.9% of the travellers in East Africa; 12.6% used it in West Africa where it is not necessary. Antimosquito measures have a high priority for travellers to tropical Africa and dissemination of this fact must be improved since only 72.6% followed through on such advice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182940     DOI: 10.1007/BF02116057

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  17 in total

1.  Malaria prophylaxis: survey of the response of British travellers to prophylactic advice.

Authors:  P A Phillips-Howard; M Blaze; M Hurn; D J Bradley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-11

2.  Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.

Authors:  M G Bamber; A T Elder; J A Gray; R A Minns
Journal:  J Infect       Date:  1986-07       Impact factor: 6.072

3.  Use of prophylaxis for malaria by American travelers to Africa and Haiti.

Authors:  H O Lobel; C C Campbell; M Pappaioanou; A Y Huong
Journal:  JAMA       Date:  1987-05-15       Impact factor: 56.272

4.  Decline in sensitivity of Plasmodium falciparum to chloroquine in The Gambia.

Authors:  A Menon; R W Snow; L Otoo; B M Greenwood
Journal:  Lancet       Date:  1987-05-02       Impact factor: 79.321

5.  Recommendations for the prevention of malaria in travelers.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1988-05-06       Impact factor: 17.586

6.  Recent trends in the importation of malaria caused by Plasmodium falciparum into the United States from Africa.

Authors:  H O Lobel; C C Campbell; I K Schwartz; J M Roberts
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

7.  Efficacy of malaria prophylaxis in American and Swiss travelers to Kenya.

Authors:  H O Lobel; J M Roberts; B Somaini; R Steffen
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

8.  Spread of chloroquine resistance in Plasmodium falciparum.

Authors:  D Payne
Journal:  Parasitol Today       Date:  1987-08

9.  Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.

Authors:  T Harinasuta; D Bunnag; R Lasserre; R Leimer; S Vinijanont
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

10.  Malaria prophylaxis: postal questionnaire survey of general practitioners in south east Wales.

Authors:  A Williams; D J Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-05
View more
  1 in total

1.  How frequent are notified severe cutaneous adverse reactions to Fansidar?

Authors:  D Stürchler; M L Mittelholzer; L Kerr
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.